Literature DB >> 27025293

Setting accelerated dissolution test for PLGA microspheres containing peptide, investigation of critical parameters affecting drug release rate and mechanism.

I Tomic1, A Vidis-Millward2, M Mueller-Zsigmondy2, J-M Cardot3.   

Abstract

The objective of this study was development of accelerated in vitro release method for peptide loaded PLGA microspheres using flow-through apparatus and assessment of the effect of dissolution parameters (pH, temperature, medium composition) on drug release rate and mechanism. Accelerated release conditions were set as pH 2 and 45°C, in phosphate buffer saline (PBS) 0.02M. When the pH was changed from 2 to 4, diffusion controlled phases (burst and lag) were not affected, while release rate during erosion phase decreased two-fold due to slower ester bonds hydrolyses. Decreasing temperature from 45°C to 40°C, release rate showed three-fold deceleration without significant change in release mechanism. Effect of medium composition on drug release was tested in PBS 0.01M (200 mOsm/kg) and PBS 0.01M with glucose (380 mOsm/kg). Buffer concentration significantly affected drug release rate and mechanism due to the change in osmotic pressure, while ionic strength did not have any effect on peptide release. Furthermore, dialysis sac and sample-and-separate techniques were used, in order to evaluate significance of dissolution technique choice on the release process. After fitting obtained data to different mathematical models, flow-through method was confirmed as the most appropriate for accelerated in vitro dissolution testing for a given formulation.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Accelerated in vitro release; Degradation; Diffusion; Drug release mechanism; PLGA microspheres

Mesh:

Substances:

Year:  2016        PMID: 27025293     DOI: 10.1016/j.ijpharm.2016.03.048

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

1.  Transitioning from a lab-scale PLGA microparticle formulation to pilot-scale manufacturing.

Authors:  Andrew Otte; Kinam Park
Journal:  J Control Release       Date:  2022-06-28       Impact factor: 11.467

2.  IVIVC of Octreotide in PLGA-Glucose Microsphere Formulation, Sandostatin® LAR.

Authors:  Jin-Sook Song; So-Yeon Kim; Jae-Hyun Nam; Jaehwi Lee; Sang-Yong Song; Hasoo Seong
Journal:  AAPS PharmSciTech       Date:  2022-09-19       Impact factor: 4.026

3.  Long-term antibacterial performances of biodegradable polylactic acid materials with direct absorption of antibiotic agents.

Authors:  Chien-Hao Chen; Yuan-Yuan Yao; Hao-Che Tang; Tung-Yi Lin; Dave W Chen; Kong-Wei Cheng
Journal:  RSC Adv       Date:  2018-05-01       Impact factor: 4.036

4.  Metal-HisTag coordination for remote loading of very small quantities of biomacromolecules into PLGA microspheres.

Authors:  Jason Albert; Rae Sung Chang; George A Garcia; Steven P Schwendeman
Journal:  Bioeng Transl Med       Date:  2022-02-17

5.  Design and In Vivo Pharmacokinetic Evaluation of Triamcinolone Acetonide Microcrystals-Loaded PLGA Microsphere for Increased Drug Retention in Knees after Intra-Articular Injection.

Authors:  Myoung Jin Ho; Hoe Taek Jeong; Sung Hyun Im; Hyung Tae Kim; Jeong Eun Lee; Jun Soo Park; Ha Ra Cho; Dong Yoon Kim; Young Wook Choi; Joon Woo Lee; Yong Seok Choi; Myung Joo Kang
Journal:  Pharmaceutics       Date:  2019-08-19       Impact factor: 6.321

6.  Dexamethasone-Loaded biodegradable magnetic microparticles for treatment of CFA-induced chronic pain in rats.

Authors:  Jin Xin; Zheng Jichun; Sun Yonghai
Journal:  Des Monomers Polym       Date:  2022-04-28       Impact factor: 3.718

7.  Comparative statistical analysis of the release kinetics models for nanoprecipitated drug delivery systems based on poly(lactic-co-glycolic acid).

Authors:  Nathaly S Heredia; Karla Vizuete; Marco Flores-Calero; Katherine Pazmiño V; Fernanda Pilaquinga; Brajesh Kumar; Alexis Debut
Journal:  PLoS One       Date:  2022-03-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.